(1S,3S)-1-(1,3-苯并二氧戊环-5-基)-2,3,4,9-四氢-1H-吡啶并[3,4-b]吲哚-3-羧酸甲酯结构式
|
常用名 | (1S,3S)-1-(1,3-苯并二氧戊环-5-基)-2,3,4,9-四氢-1H-吡啶并[3,4-b]吲哚-3-羧酸甲酯 | 英文名 | (1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester |
|---|---|---|---|---|
| CAS号 | 171596-43-3 | 分子量 | 350.36800 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C20H18N2O4 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | (1S,3S)-1-(1,3-苯并二氧戊环-5-基)-2,3,4,9-四氢-1H-吡啶并[3,4-b]吲哚-3-羧酸甲酯 |
|---|---|
| 英文名 | Methyl (1S,3S)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-β-c arboline-3-carboxylate |
| 英文别名 | 更多 |
| 分子式 | C20H18N2O4 |
|---|---|
| 分子量 | 350.36800 |
| 精确质量 | 350.12700 |
| PSA | 72.58000 |
| LogP | 3.00210 |
| InChIKey | LIPVUDSNGRJSQE-YJBOKZPZSA-N |
| SMILES | COC(=O)C1Cc2c([nH]c3ccccc23)C(c2ccc3c(c2)OCO3)N1 |
|
~%
详细
|
| 文献:LEK Pharmaceuticals d.d. Patent: EP2107059 A1, 2009 ; Location in patent: Page/Page column 9 ; |
|
~36%
(1S,3S)-1-(1,3-... 171596-43-3 |
| 文献:Daugan, Alain; Grondin, Pascal; Ruault, Cecile; Le Monnier de Gouville, Anne-Charlotte; Coste, Herve; Linget, Jean Michel; Kirilovsky, Jorge; Hyafil, Francois; Labaudinieret, Richard Journal of Medicinal Chemistry, 2003 , vol. 46, # 21 p. 4533 - 4542 |
|
~95%
(1S,3S)-1-(1,3-... 171596-43-3 |
| 文献:Xiao, Sen; Shi, Xiao-Xin; Xing, Jing; Yan, Jing-Jing; Liu, Shi-Ling; Lu, Wei-Dong Tetrahedron Asymmetry, 2009 , vol. 20, # 18 p. 2090 - 2096 |
| trans-3-Aminocyclopentanecarboxylic acid |
| (1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester |
| Tadalafil Impurity 3 |
| Tadalafil Impurity 11 |